European guidelines for workplace drug testing in oral fluid.
-
Brcak M
Greiner Bio-One GmbH, Kremsmünster, Austria.
-
Beck O
Karolinska Institutet, Department of Laboratory Medicine, Stockholm, Sweden.
-
Bosch T
Department Clinical Pharmacology & Toxicology, Hospital Pharmacy, MaastadLab, Rotterdam, Netherlands.
-
Carmichael D
AgriYork 400 Limited, York, United Kingdom.
-
Fucci N
Institute of Public Health - Section of Legal Medicine, Catholic University, Rome, Italy.
-
George C
Alere Toxicology Plc, Oxfordshire, United Kingdom.
-
Piper M
Randox Testing Services, United Kingdom.
-
Salomone A
Centro Regionale Antidoping e di Tossicologia 'A. Bertinaria', Torino, Italy.
-
Schielen W
ELDC BV / BeterVee BV, Kerkrade, Netherlands.
-
Steinmeyer S
Dräger Safety AG & Co. KGaA, Lübeck, Germany.
-
Taskinen S
VITA Laboratory, VITA Healthcare Services Ltd, Helsinki Finland.
-
Weinmann W
Institute of Forensic Medicine, University of Bern, Switzerland.
Show more…
Published in:
- Drug testing and analysis. - 2018
English
These guidelines for Legally Defensible Workplace Drug Testing have been prepared and updated by the European Workplace Drug Testing Society (EWDTS). The European Guidelines are designed to establish best practice procedures whilst allowing individual countries to operate within the requirements of national customs and legislation. The EWDTS recommends that all European laboratories that undertake legally defensible workplace drug testing should use these guidelines as a template for accreditation. These guidelines are relevant to laboratory-based testing only. These guidelines follow current best practices and are constantly under review.
-
Language
-
-
Open access status
-
green
-
Identifiers
-
-
Persistent URL
-
https://fredi.hepvs.ch/global/documents/33756
Statistics
Document views: 60
File downloads: